Peripheral Nerve Stimulators Market Research Report - Global Forecast till 2027

Global Peripheral Nerve Stimulators Market Research Report: Information by Product (Transcutaneous, Implantable), End User (Hospitals & Clinics, Ambulatory Centers, Specialty Center), Region (Americas, Europe, Asia Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6584-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of the report has been updated from 2019-2024 to 2020-2027.Cordially fill Sample form for the updated data.

Market Scenario


Peripheral nerve stimulation is commonly known as PNS, and a common method to treat chronic pain. It includes surgery that places a small electrical device next to one of the peripheral nerves. The global peripheral nerve stimulators market expected to grow significantly over the forecast period. It is anticipated that the market held a value of USD 750.36 million in 2018 and is projected to grow at a CAGR of 7.7% over the forecast period. The global peripheral nerve stimulators market is expected to grow at a significant growth rate. The major factors influencing the growth of the market include; increasing growth in technological advancement in the field of medical devices, rising economic growth, increasing geriatric devices, rising neurological disorders, rising incidence of chronic health problems, and others.


The market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. As per the statistics of WHO in 2017, around 50 million people all over the world were affected by epilepsy. Additionally, Alzheimer's Research UK stated that over 46.8 million people worldwide were affected by dementia in 2015 and was expected to reach 50 million patients in 2017. Moreover, this number would double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050.


Furthermore, Alzheimer's Disease International reported the total worldwide cost of dementia to be USD 818 billion in 2015, which represents 1.09% of the global GDP. Additionally, the cost is likely to rise to USD 1 trillion.


These huge prevalence of neurological disorders among the population and rising healthcare expenditure for neurological disorders are driving the growth of the peripheral nerve stimulators market.  


Key Players


Some of the major players operating in the global peripheral nerve stimulators market are B. Braun Melsungen AG, NeuroSigma, Inc, NeuroMetrix, Inc., Avanos Pain Management, Enteromedics, ElectroCore, Inc., Vygon SA, Boston Scientific Corporation, Medline Industries, Inc SPR Therapeutics LLC, Stimwave LLC., SUNMED INC., and others.


Intended Audience



  • Peripheral nerve stimulators manufacturers

  • Peripheral nerve stimulators distributors

  • Hospitals, clinics, and associations

  • Private insurance companies

  • Government agencies

  • Various research and consulting firms


Segmentation


The global peripheral nerve stimulators market has been segmented into product, end user, and region.


Based on product, the market is segmented into transcutaneous and implantable.


Based on end user, the peripheral nerve stimulators market is segmented into hospitals & clinics, ambulatory centers, specialty centers, and others.


The global peripheral nerve stimulators market, by region, has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The peripheral nerve stimulators market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European peripheral nerve stimulators market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The peripheral nerve stimulators market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The peripheral nerve stimulators market in the Middle East & Africa has been segmented into the Middle East and Africa.


Global Peripheral Nerve Stimulators Market Share (%), by Region, 2018  Peripheral Nerve Stimulators Market_Image


Source: Annual Reports and Sec filings Regional Market Summary


Geographically, the Americas is anticipated to dominate the global peripheral nerve stimulators market owing to the presence of major players, huge neurological disorders patient population, increasing adoption of advanced technology in the field of medical device, in the region.


Europe is expected to hold the second largest position in the global peripheral nerve stimulators market.


Asia-Pacific is the fastest growing peripheral nerve stimulators market owing to the increasing geriatric population, the presence of a huge patient pool and rapidly improving the technology.


The Middle East and Africa market for Peripheral Nerve Stimulators is expected to grow at a steady pace.


Global Peripheral Nerve Stimulators Market, by Product



  • Transcutaneous

  • Implantable


Global Peripheral Nerve Stimulators Market, by End User



  • Hospitals & Clinics

  • Ambulatory Centers

  • Specialty Center

  • Others


Global Peripheral Nerve Stimulators Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa





Frequently Asked Questions (FAQ) :


Peripheral Nerve Stimulators Market was valued at USD 750.36 million in 2018.

Peripheral Nerve Stimulators Market is expected to exhibit a strong 7.7% CAGR over the forecast period from 2019 to 2024.

The increasing prevalence of chronic neurological disorders is the major driver for the global peripheral nerve stimulators market.

The Americas hold the dominant share in the global market.

Leading players in the global peripheral nerve stimulators market include NeuroSigma Inc., B. Braun Melsungen, ElectroCore Inc., Avanos Pain Management, Vygon SA, SUNMED Inc., Stimwave LLC, and Boston Scientific Corporation, among others.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Typology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

Chapter 6. Global Peripheral Nerve Stimulators Market, by Product

6.1 Introduction

6.2 Transcutaneous

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Implantable

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Peripheral Nerve Stimulators Market, by End User

7.1 Introduction

7.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Ambulatory Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Specialty Center

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Peripheral Nerve Stimulators Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 Latin America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 B. Braun Melsungen AG.

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Avanos Pain Management.

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Enteromedics

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 ElectroCore, Inc.

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 NeuroSigma, Inc

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial Overview

10.5.4 Key Development

10.5.5 SWOT Analysis

10.6 NeuroMetrix, Inc.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Development

10.6.5 SWOT Analysis

10.7 SPR Therapeutics LLC

10.7.1 Company Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Development

10.7.5 SWOT Analysis

10.8 Stimwave LLC.

10.8.1 Company Overview

10.8.2 Product Overview

10.8.3 Financial Overview

10.8.4 Key Development

10.8.5 SWOT Analysis

10.9 SUNMED INC.

10.9.1 Company Overview

10.9.2 Product Overview

10.9.3 Financial Overview

10.9.4 Key Development

10.9.5 SWOT Analysis

10.10 Vygon SA

10.10.1 Company Overview

10.10.2 Product Overview

10.10.3 Financial Overview

10.10.4 Key Development

10.10.5 SWOT Analysis

10.10 Boston Scientific Corporation

10.10.1 Company Overview

10.10.2 Product Overview

10.10.3 Financial Overview

10.10.4 Key Development

10.10.5 SWOT Analysis

10.12 Medline Industries, Inc

10.12.1 Company Overview

10.12.2 Product Overview

10.12.3 Financial Overview

10.12.4 Key Development

10.12.5 SWOT Analysis

10.13 Others

Chapter 12. Appendix


LIST OF TABLES

Table 1 Global Peripheral Nerve Stimulators Market Synopsis, 2020-2027

Table 2 Global Peripheral Nerve Stimulators Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Peripheral Nerve Stimulators Market, by Region, 2020-2027(USD Million)

Table 4 Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 5 Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 6 North America: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 7 North America: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 8 US: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 9 US: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 10 Canada: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 11 Canada: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 12 Latin America: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 13 Latin America: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 14 Europe: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 15 Europe: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 16 Western Europe: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 17 Western Europe: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 18 Eastern Europe: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 19 Eastern Europe: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 20 Asia-Pacific: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 21 Asia-Pacific: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million)

Table 22 Middle East & Africa: Global Peripheral Nerve Stimulators Market, by Product, 2020-2027(USD Million)

Table 23 Middle East & Africa: Global Peripheral Nerve Stimulators Market, by End User, 2020-2027(USD Million) 

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Peripheral Nerve Stimulators Market

Figure 3 Segmentation Market Dynamics for Global Peripheral Nerve Stimulators Market

Figure 4 Global Peripheral Nerve Stimulators Market Share, by Product, 2020

Figure 5 Global Peripheral Nerve Stimulators Market Share, by End User, 2020

Figure 6 Global Peripheral Nerve Stimulators Market Share, by Region, 2020

Figure 7 North America: Global Peripheral Nerve Stimulators Market Share, by Country, 2020

Figure 8 Europe: Global Peripheral Nerve Stimulators Market Share, by Country, 2020

Figure 9 Asia-Pacific: Global Peripheral Nerve Stimulators Market Share, by Country, 2020

Figure 10 Middle East & Africa: Global Peripheral Nerve Stimulators Market Share, by Country, 2020

Figure 11 Global Peripheral Nerve Stimulators Market: Company Share Analysis, 2020 (%)

Figure 12 B. Braun Melsungen AG: Overview

Figure 13 B. Braun Melsungen AG: Key Financials

Figure 14 B. Braun Melsungen AG: Segmental Revenue

Figure 15 B. Braun Melsungen AG: Geographical Revenue

Figure 16 Avanos Pain Management

Figure 17 Enteromedics

Figure 18 ElectroCore, Inc.

Figure 19 NeuroSigma, Inc

Figure 20 NeuroMetrix, Inc.

Figure 21 SPR Therapeutics LLC

Figure 22 Stimwave LLC.

Figure 23 SUNMED INC.

Figure 24 Vygon SA

Figure 25 Boston Scientific Corporation3

Figure 26 Medline Industries, Inc.




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.